HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sheridan M Hoy Selected Research

Pharmaceutical Preparations

6/2022Oteseconazole: First Approval.
4/2020Tazemetostat: First Approval.
11/2018Fremanezumab: First Global Approval.
10/2018Patisiran: First Global Approval.
3/2018Netarsudil Ophthalmic Solution 0.02%: First Global Approval.
4/2016Dinutuximab: A Review in High-Risk Neuroblastoma.
4/2016Carfilzomib Triple Combination Therapy: A Review in Relapsed Multiple Myeloma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sheridan M Hoy Research Topics

Disease

10Pain (Aches)
05/2022 - 01/2008
9Neoplasms (Cancer)
11/2020 - 01/2008
7Seizures (Absence Seizure)
01/2018 - 08/2013
5Infections
09/2021 - 02/2015
5Disease Progression
06/2020 - 01/2006
5Neutropenia
04/2019 - 10/2014
5Ocular Hypertension (Glaucoma, Suspect)
05/2018 - 01/2006
5Open-Angle Glaucoma (Glaucoma, Open Angle)
05/2018 - 01/2006
4Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2022 - 01/2018
4Headache (Headaches)
11/2018 - 04/2013
4Epilepsy (Aura)
01/2018 - 08/2013
4Multiple Myeloma
11/2017 - 10/2012
4Nausea
05/2015 - 01/2009
3Prostatic Neoplasms (Prostate Cancer)
10/2020 - 12/2013
3Parkinson Disease (Parkinson's Disease)
10/2019 - 03/2012
3Breast Neoplasms (Breast Cancer)
04/2019 - 12/2018
3Thrombocytopenia (Thrombopenia)
11/2017 - 10/2010
3Inflammation (Inflammations)
11/2017 - 08/2015
3Hypertension (High Blood Pressure)
12/2013 - 01/2010
3Bradycardia
08/2012 - 08/2009
2Atopic Dermatitis (Atopic Eczema)
05/2022 - 12/2017
2Pruritus (Itching)
05/2022 - 12/2017
2Chronic Renal Insufficiency
09/2021 - 10/2018
2Lung Diseases (Lung Disease)
06/2021 - 04/2021
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
02/2021 - 02/2019
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
11/2020 - 04/2020
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
11/2020 - 04/2020
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2020 - 10/2012
2Diabetes Mellitus
04/2020 - 01/2020
2Febrile Neutropenia
04/2019 - 02/2019
2Migraine Disorders (Migraine)
11/2018 - 04/2011
2Heart Failure
10/2018 - 05/2014
2Necrosis
04/2017 - 01/2007
2Type 2 Diabetes Mellitus (MODY)
04/2017 - 04/2013
2Hemorrhage
08/2016 - 08/2009
2Dizziness (Lightheadedness)
08/2016 - 12/2013
2Abdominal Pain (Pain, Abdominal)
05/2015 - 01/2009
2Peripheral Nervous System Diseases (PNS Diseases)
10/2014 - 01/2013
2Hypotension (Low Blood Pressure)
08/2012 - 07/2011
2Respiratory Insufficiency (Respiratory Failure)
08/2012 - 07/2011
2Chronic Pain
02/2012 - 01/2008
2Colorectal Neoplasms (Colorectal Cancer)
01/2007 - 01/2006
1Mycoses (Diseases, Fungus)
06/2022
1Rheumatoid Arthritis
05/2022
1Myositis Ossificans (Fibrodysplasia Ossificans Progressiva)
04/2022
1Heterotopic Ossification (Ectopic Ossification)
04/2022
1Chronic Obstructive Pulmonary Disease (COPD)
03/2022
1Asthma (Bronchial Asthma)
03/2022
1Chronic Urticaria
03/2022
1Diabetic Foot
09/2021
1Soft Tissue Infections
09/2021
1Secondary Hyperparathyroidism
09/2021

Drug/Important Bio-Agent (IBA)

7Pharmaceutical PreparationsIBA
06/2022 - 04/2016
4Ophthalmic Solutions (Eye Drops)IBA
05/2018 - 08/2015
3nusinersenIBA
01/2022 - 01/2018
3SuspensionsIBA
06/2021 - 10/2019
3Lenalidomide (CC 5013)FDA Link
11/2020 - 04/2016
3Adrenal Cortex Hormones (Corticosteroids)IBA
05/2020 - 04/2015
3Biosimilar PharmaceuticalsIBA
04/2020 - 02/2019
3Levodopa (L Dopa)FDA LinkGeneric
10/2019 - 03/2012
3Monoclonal AntibodiesIBA
11/2018 - 01/2006
3Timolol (Blocadren)FDA LinkGeneric
05/2018 - 01/2006
2Cyclosporine (Ciclosporin)FDA LinkGeneric
05/2022 - 11/2017
2Biological ProductsIBA
03/2022 - 04/2020
2Liposomes (Liposome)IBA
06/2021 - 04/2021
2Amikacin (A.M.K)FDA LinkGeneric
06/2021 - 04/2021
2Tyrosine Kinase InhibitorsIBA
02/2021 - 05/2014
2Insulin Glargine (Lantus)FDA Link
04/2020 - 01/2020
2pegfilgrastim (Neulasta)FDA Link
04/2019 - 02/2019
2BOL 303259-XIBA
05/2018 - 01/2018
2LacosamideFDA Link
01/2018 - 12/2013
2Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2007
2Ointments (Pastes)IBA
12/2017 - 08/2012
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2017 - 04/2016
2Bortezomib (Velcade)FDA Link
11/2017 - 01/2013
2Synthetic Prostaglandins (Prostaglandin Analogues)IBA
10/2015 - 01/2006
2Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
02/2015 - 01/2009
2Zonisamide (Zonegran)FDA LinkGeneric
06/2014 - 08/2013
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2013 - 08/2013
2rasagiline (Azilect)FDA Link
09/2012 - 03/2012
2DexmedetomidineFDA Link
08/2012 - 07/2011
2candesartan cilexetil (Amias)FDA Link
02/2012 - 01/2010
2Panitumumab (Vectibix)FDA Link
01/2007 - 01/2006
1AzolesIBA
06/2022
1Antifungal AgentsIBA
06/2022
1baricitinibIBA
05/2022
1Janus KinasesIBA
05/2022
1PalovaroteneIBA
04/2022
1Retinoic Acid Receptors (Retinoic Acid Receptor)IBA
04/2022
1tezepelumabIBA
03/2022
1Thymic Stromal LymphopoietinIBA
03/2022
1CytokinesIBA
03/2022
1contezolidIBA
09/2021
1upacicalcetIBA
09/2021
1Methicillin (Metin)FDA Link
09/2021
1Complement System Proteins (Complement)IBA
08/2021
1Complement C3 (C3 Complement)IBA
08/2021

Therapy/Procedure

41Therapeutics
05/2022 - 01/2006
5Drug Therapy (Chemotherapy)
04/2019 - 10/2010
3Castration
10/2020 - 12/2013